Effects of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) Taking Anti-Acid Therapy
TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD | May 4, 2021 | Volume: No volume available | Issue: No issue available | Pages: A1906-A1906
10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1906